Search

everythinglearnresearchcommunity

for

Search:↓

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Diphencyprone helped most patients with alopecia areata regrow some hair.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

HIV can cause unusual and severe skin problems that are hard to treat.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Baricitinib may effectively treat oral lichen planus.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

A man in Japan got better from a scalp fungal infection using terbinafine.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.